EUVIMEDEUVIMED entdecken
Crossref

The placental transcriptomic profile determined by maternal COVID-19 disease encompasses alterations reminiscent of preeclampsia

Ana Medel-Martinez, Mark Strunk, Alberto Cebollada-Solanas, Laura Puente-Santamaría, Sonia Gómez-Muñoz, Marta Fabre, Cristina Paules, Daniel Oros, Jon Schoorlemmer

Placenta · 2025

DOI: 10.1016/j.placenta.2025.02.018 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Placenta, 2025. Verfasst von Ana Medel-Martinez und 8 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Investigación Sanitario de Aragón (IIS Aragón) , Spain; Maternal and Fetal Health Research Group, GIIS-106 del IISA, Spain. Hauptthemen laut MEDLINE: COVID-19, Placenta, Pre-Eclampsia, Transcriptome. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Gobierno de Aragón, Federación Española de Enfermedades Raras, Instituto de Salud Carlos III.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: During initial stages of the pandemic, SARS-CoV-2 infection during pregnancy was related to adverse pregnancy outcomes and alterations in the placenta. Whether placental abnormalities in pregnant women with COVID-19 still persist afterwards remains poorly studied. Here, we determined whether the absence of obstetric complications after maternal COVID-19 disease, including preeclampsia, is accompanied by a complete return to normalcy in terms of placental physiology. METHODS: Placental RNA was purified from placental samples from SARS-CoV-2 positive mothers taken either in 2022, when Omicron was the predominant variant of concern (termed Omicron) (n = 21); or from healthy pregnancies predating the pandemic (termed preCOVID-19). Our cohort included samples from pregnant women who got infected weeks and even months before term. We performed RNA-seq, identified differentially expressed genes and examined to which biological, biochemical and cellular pathways they belong, using gene set enrichment analysis. RESULTS: We identified 71 differentially expressed genes (DEGs) (defined by p-value ≤0.05 and fold change (FC) of ≤ -2 or ≥2). The alterations identified in placentas delivered by mothers who suffered an episode of COVID-19 disease could be mainly attributed to pathways related to organogenesis, extracellular matrix organization and oxygen transport. These alterations were also detected after exclusion of gestational diabetes mellitus (GDM) samples. Although none of the samples were taken from cases of preeclampsia, several of the relevant DEGs have been previously reported as dysregulated in hypertensive disorders of pregnancy including preeclampsia. DISCUSSION: We propose that maternal SARS-CoV-2 infection causes alterations in gene expression that are indicative of vascular defects in the placenta.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19PlacentaPre-EclampsiaTranscriptomePregnancy Complications, InfectiousHumansFemalePregnancyAdultSARS-CoV-2Gene Expression Profiling

Stichwörter der Autor:innen

Gene expressionOrganogenesisOxygen metabolismPlacental parenchymaSARS-CoV-2Vascular defects

Autor:innen und Institutionen

  • Instituto de Investigación Sanitario de Aragón (IIS Aragón) , Spain; Maternal and Fetal Health Research Group, GIIS-106 del IISA, Spain.
  • Instituto Aragonés de Ciencias de La Salud (IACS), Centro de Investigación Biomédica de Aragón (CIBA), Zaragoza, Spain.
  • Biocomputing Unit. Health Services and Policy Research Group (ARiHSP), Instituto Aragonés de Ciencias de la Salud (IACS), Zaragoza, Spain; Instituto Aragonés de Ciencias de La Salud (IACS), Centro de Investigación Biomé…
  • Instituto de Investigación Sanitario de Aragón (IIS Aragón) , Spain.
  • Instituto de Investigación Sanitario de Aragón (IIS Aragón) , Spain; Placental Pathophysiology & Fetal Programming Research Group, GIIS-028 del IISA, Spain; Red RICORS "Primary Care Interventions to Prevent Maternal and…
  • Instituto de Investigación Sanitario de Aragón (IIS Aragón) , Spain; Maternal and Fetal Health Research Group, GIIS-106 del IISA, Spain; Obstetrics Department, Hospital Clínico Universitario Lozano Blesa Zaragoza, Zarag…

Förderung

  • Gobierno de Aragón
  • Federación Española de Enfermedades Raras
  • Instituto de Salud Carlos III

Zitieren

APA

Medel-Martinez, A., Strunk, M., Cebollada-Solanas, A., Puente-Santamaría, L., Gómez-Muñoz, S., Fabre, M., Paules, C., Oros, D., & Schoorlemmer, J. (2025). The placental transcriptomic profile determined by maternal COVID-19 disease encompasses alterations reminiscent of preeclampsia. Placenta. https://doi.org/10.1016/j.placenta.2025.02.018

Vancouver

Medel-Martinez A, Strunk M, Cebollada-Solanas A, Puente-Santamaría L, Gómez-Muñoz S, Fabre M, et al. The placental transcriptomic profile determined by maternal COVID-19 disease encompasses alterations reminiscent of preeclampsia. Placenta. 2025. doi:10.1016/j.placenta.2025.02.018

BibTeX
@article{MedelMartinez2025,
  author = {Medel-Martinez, Ana and Strunk, Mark and Cebollada-Solanas, Alberto and Puente-Santamaría, Laura and Gómez-Muñoz, Sonia and Fabre, Marta and Paules, Cristina and Oros, Daniel and Schoorlemmer, Jon},
  title = {The placental transcriptomic profile determined by maternal COVID-19 disease encompasses alterations reminiscent of preeclampsia},
  journal = {Placenta},
  year = {2025},
  doi = {10.1016/j.placenta.2025.02.018}
}
Kostenlos starten →